English
繁體中文
简体中文
日本語
About
Urs Frey is the CEO at MaxWell Biosystems and a member of the founding team. Urs is responsible for running MaxWell Biosystems, business development, finances and product design.
Urs earned his PhD in Electrical Engineering at ETH Zurich before moving to at IBM Research, where he did a postdoc on mixed-signal circuit design. Later, Urs was heading an independent laboratory focusing on CMOS-based bioelectronics and biosensors at RIKEN, Japan. During the past 15 years he has built up considerable experience in project and people management. Urs is the innovator of the “switch-matrix” architecture of our microelectrode arrays.